Scott Arnold Mcintyre, APRN | |
22 Westfield Ave, Ansonia, CT 06401-1158 | |
(203) 736-9919 | |
(203) 735-2055 |
Full Name | Scott Arnold Mcintyre |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 6 Years |
Location | 22 Westfield Ave, Ansonia, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528554094 | NPI | - | NPPES |
RN2319173 | Other | MA | COMMONWEALTH OF MASSACHUSETTS BOARD OF NURSING |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LP2300X | Nurse Practitioner - Primary Care | 8220 (Connecticut) | Secondary |
363LA2200X | Nurse Practitioner - Adult Health | 8220 (Connecticut) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Griffin Hospital | Derby, CT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Griffin Faculty Physicians Inc | 7618871997 | 107 |
News Archive
Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the possibility of adverse side effects when deciding between strategies. New research in the latest issue of General Hospital Psychiatry now suggests one strategy may not be any more likely to be harmful than the other.
Scientists at the University of Massachusetts Medical School and the University of Texas at Austin have uncovered evidence that environmental influences experienced by a father can be passed down to the next generation, "reprogramming" how genes function in offspring. A new study published this week in Cell shows that environmental cues-in this case, diet-influence genes in mammals from one generation to the next, evidence that until now has been sparse.
Extending NHS weight loss programmes from one session per week for 12-weeks to one session per week for a year helped people who are overweight to lose more weight and keep it off for longer, according to a study published in The Lancet, and led by researchers from the University of Cambridge, University of Liverpool and University of Oxford.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 3 days ago
Entity Name | Griffin Faculty Physicians Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598755605 PECOS PAC ID: 7618871997 Enrollment ID: O20031120000158 |
News Archive
Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the possibility of adverse side effects when deciding between strategies. New research in the latest issue of General Hospital Psychiatry now suggests one strategy may not be any more likely to be harmful than the other.
Scientists at the University of Massachusetts Medical School and the University of Texas at Austin have uncovered evidence that environmental influences experienced by a father can be passed down to the next generation, "reprogramming" how genes function in offspring. A new study published this week in Cell shows that environmental cues-in this case, diet-influence genes in mammals from one generation to the next, evidence that until now has been sparse.
Extending NHS weight loss programmes from one session per week for 12-weeks to one session per week for a year helped people who are overweight to lose more weight and keep it off for longer, according to a study published in The Lancet, and led by researchers from the University of Cambridge, University of Liverpool and University of Oxford.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 3 days ago
Entity Name | Connecticut Gastroenterology Assoc Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700917523 PECOS PAC ID: 8123083193 Enrollment ID: O20041201000669 |
News Archive
Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the possibility of adverse side effects when deciding between strategies. New research in the latest issue of General Hospital Psychiatry now suggests one strategy may not be any more likely to be harmful than the other.
Scientists at the University of Massachusetts Medical School and the University of Texas at Austin have uncovered evidence that environmental influences experienced by a father can be passed down to the next generation, "reprogramming" how genes function in offspring. A new study published this week in Cell shows that environmental cues-in this case, diet-influence genes in mammals from one generation to the next, evidence that until now has been sparse.
Extending NHS weight loss programmes from one session per week for 12-weeks to one session per week for a year helped people who are overweight to lose more weight and keep it off for longer, according to a study published in The Lancet, and led by researchers from the University of Cambridge, University of Liverpool and University of Oxford.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Scott Arnold Mcintyre, APRN 67 Maple Ave, Derby, CT 06418-1328 Ph: () - | Scott Arnold Mcintyre, APRN 22 Westfield Ave, Ansonia, CT 06401-1158 Ph: (203) 736-9919 |
News Archive
Patients with major depression who fail to see improvement after taking an antidepressant often have their initial medication switched or combined with a second drug. Many clinicians weigh the possibility of adverse side effects when deciding between strategies. New research in the latest issue of General Hospital Psychiatry now suggests one strategy may not be any more likely to be harmful than the other.
Scientists at the University of Massachusetts Medical School and the University of Texas at Austin have uncovered evidence that environmental influences experienced by a father can be passed down to the next generation, "reprogramming" how genes function in offspring. A new study published this week in Cell shows that environmental cues-in this case, diet-influence genes in mammals from one generation to the next, evidence that until now has been sparse.
Extending NHS weight loss programmes from one session per week for 12-weeks to one session per week for a year helped people who are overweight to lose more weight and keep it off for longer, according to a study published in The Lancet, and led by researchers from the University of Cambridge, University of Liverpool and University of Oxford.
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today new data that showed a vast majority of patients with moderate to severe plaque psoriasis receiving TREMFYA (guselkumab), who achieved at least a 90 percent improvement in the Psoriasis Area and Severity Index (PASI 90) at week 28, maintained a PASI 90 response with continuous treatment through week 72.
› Verified 3 days ago
Cecrystal Umeugo, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 5 Shortell Drive, Ansonia, CT 06401 Phone: 203-906-6486 | |
Ms. Judith Heller, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 135 Division Street 1st Floor, Ansonia, CT 06401 Phone: 203-735-3500 Fax: 203-735-0505 | |
Gena Marie Borgman, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 22 Westfield Ave Ste 1, Ansonia, CT 06401 Phone: 203-308-2781 | |
Theresa Conroy, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 24 Pershing Dr # 36, Ansonia, CT 06401 Phone: 612-225-1534 | |
Leina Grecia Fruhbauer, NPP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 435 E Main St, Ansonia, CT 06401 Phone: 203-736-2601 | |
Kathia Fonseca, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 435 E Main St, Ansonia, CT 06401 Phone: 203-736-2601 | |
Mr. Francis Gorman, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 121 Wakelee Ave, Ansonia, CT 06401 Phone: 203-503-3570 Fax: 203-503-3589 |